Phase II study of A Prospective Phase II Trial of NovoTTF-100A with Bevacizumab (Avastin) in Patients with Recurrent Glioblastoma The goal of this study is to determine

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/13 → 1/1/20

Funding

  • Novocure: $611,140.00